Search This Blog

Tuesday, October 29, 2019

PTC Therapeutics EPS misses by $0.27, misses on revenue

PTC Therapeutics (NASDAQ:PTCT): Q3 GAAP EPS of -$1.06 misses by $0.27.
Revenue of $71.42M (+33.3% Y/Y) misses by $1.61M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)